MammoScreen BD
510(k) K241561
MammoScreen BD is a medical device (FDA Class II; FDA product code QIH, Automated Radiological Image Processing Software) made by Therapixel, cleared under FDA 510(k) K241561 on 2 Oct 2024, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK241561 | Date2 Oct 2024 | StatusActive |
Official records
- FDA 510(k) database K241561
From the FDA record
- Received by the FDA
- 31 May 2024
- FDA decision
- 2 Oct 2024 (Substantially Equivalent)
- FDA review time
- 124 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QIH
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).
- i2Contour by Mrimath, LLC
- Medihub Prostate by JLK, Inc.
- Data Analysis Facilitation Suite (DAFS) by Voronoi Health Analytics Incorporated
- uSONIQUE uSONIQUE Venus Elite by Wuhan United Imaging Healthcare Co., Ltd.
- uSONIQUE uSONIQUE Genesis by Wuhan United Imaging Healthcare Co., Ltd.
- Morph by BeauBrain Healthcare, Inc.
- RadioLens v1.0 by Synapsica
- NeuroQuant by CORTECHS LABS INC
- Arterys MICA by Arterys Inc.
- cmAngio V1.0 by Curemetrix, Inc.